Segall Bryant & Hamill’s Elevance Health ELV Stock Holding History

Segall Bryant & Hamill’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-683	Closed	-$261K	–	789
2021 Q2	$261K	Sell	683 -142	-17%	-$54.3K	﹤0.01%	707
2021 Q1	$296K	Buy	825 +100	+14%	+$32.2K	﹤0.01%	727
2020 Q4	$233K	Buy	+725	New	+$222K	﹤0.01%	691
2020 Q1	–	Sell	-779	Closed	-$235K	–	803
2019 Q4	$235K	Sell	779 -171	-18%	-$47.1K	﹤0.01%	768
2019 Q3	$227K	Hold	950	–	–	﹤0.01%	776
2019 Q2	$269K	Hold	950	–	–	﹤0.01%	755
2019 Q1	$272K	Buy	+950	New	+$275K	﹤0.01%	759
2018 Q3	–	Sell	-1,050	Closed	-$250K	–	850
2018 Q2	$250K	Buy	+1,050	New	+$243K	﹤0.01%	784

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Segall Bryant & Hamill's ELV Position: Q3 2021 in Review

Segall Bryant & Hamill sold out of Elevance Health (ELV) in Q3 2021, closing a stake of 683 shares — an estimated $261K sold.

Segall Bryant & Hamill first reported a position in ELV in Q2 2018 and held it in 8 quarters. The position peaked at $296K in Q1 2021. 1,214 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

Segall Bryant & Hamill reported no remaining Elevance Health position as of Q3 2021 after selling out during the quarter.
Segall Bryant & Hamill sold 683 Elevance Health shares in Q3 2021, an estimated $261K.
Segall Bryant & Hamill first reported a position in Elevance Health in Q2 2018 and held it in 8 quarters.
Segall Bryant & Hamill's Elevance Health position peaked at $296K in Q1 2021.
1,214 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on Segall Bryant & Hamill's 13F filing for Q3 2021, filed 3 Nov 2021.